Suppr超能文献

过敏性紫癜性肾炎的预后预测因素。

Predictors of outcome in Henoch-Schönlein nephritis.

机构信息

Department of Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska Institutet, Astrid Lindgren Children s Hospital, Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden.

出版信息

Pediatr Nephrol. 2010 Jun;25(6):1101-8. doi: 10.1007/s00467-010-1444-y. Epub 2010 Feb 20.

Abstract

Factors predictive of renal outcome were studied in 78 children with Henoch-Schönlein nephritis followed up for as long as 17 (mean 5.2) years. Patients with a good outcome (74%) were healthy or had microalbuminuria or mild proteinuria at the final follow-up (FU), and those with poor outcome (26%) had active renal disease or chronic kidney disease at stages IV-V. Patients with mild symptoms at onset (hematuria + or - mild proteinuria) had a poor outcome in 15% of cases versus 41% of those with severe symptoms (nephritic or nephrotic syndrome or nephritic-nephrotic picture) (p = 0.011). However, among patients with mild proteinuria at onset, 18% showed a poor prognosis; non-nephrotic proteinuria with a urine albumin/creatinine ratio at a cut-off value of >144 mg/mmol at the 1-year FU was predictive of a poor outcome. Among 59 biopsied patients, 37% of those with advanced histological findings [International Study of Kidney Disease in Children (ISKDC) stages III-V] had a poor outcome compared to none of those with mild findings (ISKDC stages I-II) (p = 0.0015). Patients with a poor outcome were older at onset, had more proteinuria, and lower glomerular filtration rate at the 1-year FU compared with patients with a good outcome. Multivariate analysis showed that proteinuria at the 1-year FU and the ISKDC grading score of the renal biopsy were the two most discriminant factors of a poor prognosis.

摘要

对 78 例接受随访长达 17 年(平均 5.2 年)的过敏性紫癜肾炎患儿的肾脏预后相关因素进行了研究。在最终随访时,预后良好(74%)的患者健康或仅存在微量白蛋白尿或轻度蛋白尿,而预后不良(26%)的患者存在活动性肾脏疾病或慢性肾脏病 IV-V 期。在发病时症状较轻(血尿+或-轻度蛋白尿)的患者中,15%的预后不良,而在发病时症状较重(肾炎或肾病综合征或肾炎-肾病综合征表现)的患者中,这一比例为 41%(p=0.011)。然而,在发病时即存在轻度蛋白尿的患者中,18%的患者预后不良;在发病时尿白蛋白/肌酐比值大于 144mg/mmol 的非肾病范围蛋白尿,在 1 年随访时提示预后不良。在 59 例接受活检的患者中,37%的患者存在晚期组织学发现(国际儿童肾脏病研究组织 [ISKDC] 分期 III-V 期),而无 1 例存在轻度组织学发现(ISKDC 分期 I-II 期)的患者预后不良(p=0.0015)。与预后良好的患者相比,预后不良的患者发病年龄更大,蛋白尿更多,1 年随访时肾小球滤过率更低。多变量分析显示,1 年随访时的蛋白尿和肾活检的 ISKDC 分级评分是预后不良的两个最具鉴别力的因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验